PGC1β activates an antiangiogenic program to repress neoangiogenesis in muscle ischemia

Cell Reports

Volumn 8, Issue 3, 2014, Pages 783-797

  Yadav, Vikas ^a   Matsakas, Antonios ^a   Lorca, Sabina ^a   Narkar, Vihang A ^a,b  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF TEXAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOPOIETIN 1; ANGIOPOIETIN 2; CHICKEN OVALBUMIN UPSTREAM PROMOTER TRANSCRIPTION FACTOR 1; FIBROBLAST GROWTH FACTOR 1; FIBROBLAST GROWTH FACTOR 2; HYPOXIA INDUCIBLE FACTOR; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA COACTIVATOR 1BETA; PIGMENT EPITHELIUM DERIVED FACTOR; PLATELET DERIVED GROWTH FACTOR B; THROMBOSPONDIN 1; THROMBOSPONDIN 2; VASCULOTROPIN C; VASCULOTROPIN D;

ANGPT1 GENE; ANGPT2 GENE; ANGSTAT GENE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENDOTHELIUM CELL; FGF1 GENE; FGF2 GENE; GENE; GENE CONTROL; GENE REPRESSION; HYPOXIA; MALE; MOUSE; MUSCLE BLOOD FLOW; MUSCLE CELL; MUSCLE ISCHEMIA; NEOVASCULARIZATION (PATHOLOGY); NONHUMAN; PDGFB GENE; PEDF GENE; PRIORITY JOURNAL; PROTEIN FUNCTION; REVASCULARIZATION; SIGNAL TRANSDUCTION; THBS1 GENE; THBS2 GENE; VASH1 GENE; VEGFC GENE; VEGFD GENE;

EID: 84924545775     PISSN: None     EISSN: 22111247     Source Type: Journal    
DOI: 10.1016/j.celrep.2014.06.040     Document Type: Article

References (41)

1. Akimoto, T., Pohnert, S.C., Li, P., Zhang, M., Gumbs, C., Rosenberg, P.B., Williams, R.S., and Yan, Z. (2005). Exercise stimulates Pgc-1alpha transcription in skeletal muscle through activation of the p38 MAPK pathway. J. Biol. Chem. 280, 19587-19593.
2. Arany, Z., Lebrasseur, N., Morris, C., Smith, E., Yang, W., Ma, Y., Chin, S., and Spiegelman, B.M. (2007). The transcriptional coactivator PGC-1beta drives the formation of oxidative type IIX fibers in skeletal muscle. Cell Metab. 5, 35-46.
3. Arany, Z., Foo, S.Y., Ma, Y., Ruas, J.L., Bommi-Reddy, A., Girnun, G., Cooper, M., Laznik, D., Chinsomboon, J., Rangwala, S.M., et al. (2008). HIF-independent regulation of VEGF and angiogenesis by the transcriptional coactivator PGC-1alpha. Nature 451, 1008-1012.
4. Baumgartner, I., Schainfeld, R., and Graziani, L. (2005). Management of peripheral vascular disease. Annu. Rev. Med. 56, 249-272.
5. Cao, Y., Hong, A., Schulten, H., and Post, M.J. (2005). Update on therapeutic neovascularization. Cardiovasc. Res. 65, 639-648.
6. Carmeliet, P., and Jain, R.K. (2011). Molecular mechanisms and clinical applications of angiogenesis. Nature 473, 298-307.
7. Cartoni, R., Léger, B., Hock, M.B., Praz, M., Crettenand, A., Pich, S., Ziltener, J.L., Luthi, F., Dériaz, O., Zorzano, A., et al. (2005). Mitofusins 1/2 and ERRalpha expression are increased in human skeletal muscle after physical exercise. J. Physiol. 567, 349-358.
8. Chi, Y.W., Osinbowale, O., and Milani, R. (2011). Genetic association studies in peripheral arterial disease. J. La. State Med. Soc. 163, 30-34, 36-37, 39.
9. Chinsomboon, J., Ruas, J., Gupta, R.K., Thom, R., Shoag, J., Rowe, G.C., Sawada, N., Raghuram, S., and Arany, Z. (2009). The transcriptional coactivator PGC-1alpha mediates exercise-induced angiogenesis in skeletal muscle. Proc. Natl. Acad. Sci. USA 106, 21401-21406.
10. Chung, A.S., Lee, J., and Ferrara, N. (2010). Targeting the tumour vasculature: insights from physiological angiogenesis. Nat. Rev. Cancer 10, 505-514.
11. Costa, P.Z., and Soares, R. (2013). Neovascularization in diabetes and its complications. Unraveling the angiogenic paradox. Life Sci. 92, 1037-1045.
12. Finck, B.N., and Kelly, D.P. (2006). PGC-1 coactivators: inducible regulators of energy metabolism in health and disease. J. Clin. Invest. 116, 615-622.
13. Gaudel, C., Schwartz, C., Giordano, C., Abumrad, N.A., and Grimaldi, P.A. (2008). Pharmacological activation of PPARbeta promotes rapid and calcineurin-dependent fiber remodeling and angiogenesis in mouse skeletal muscle. Am. J. Physiol. Endocrinol. Metab. 295, E297-E304.
14. Guarani, V., Deflorian, G., Franco, C.A., Krüger, M., Phng, L.K., Bentley, K., Toussaint, L., Dequiedt, F., Mostoslavsky, R., Schmidt, M.H., et al. (2011). Acetylation-dependent regulation of endothelial Notch signalling by the SIRT1 deacetylase. Nature 473, 234-238.
15. Han, J.K., Kim, H.L., Jeon, K.H., Choi, Y.E., Lee, H.S., Kwon, Y.W., Jang, J.J., Cho, H.J., Kang, H.J., Oh, B.H., et al. (2013). Peroxisome proliferator-activated receptor-δ activates endothelial progenitor cells to induce angio-myogenesis through matrix metallo-proteinase-9-mediated insulin-like growth factor-1 paracrine networks. Eur. Heart J. 34, 1755-1765.
16. Kivelä, R., Silvennoinen, M., Touvra, A.M., Lehti, T.M., Kainulainen, H., and Vihko, V. (2006). Effects of experimental type 1 diabetes and exercise training on angiogenic gene expression and capillarization in skeletal muscle. FASEB J. 20, 1570-1572.
17. Lawler, P.R., and Lawler, J. (2012). Molecular basis for the regulation of angiogenesis by thrombospondin-1 and-2. Cold Spring Harb Perspect Med 2, a006627.
18. Lekas, M., Lekas, P., Latter, D.A., Kutryk, M.B., and Stewart, D.J. (2006). Growth factor-induced therapeutic neovascularization for ischaemic vascular disease: time for a re-evaluation? Curr. Opin. Cardiol. 21, 376-384.
19. Lin, J., Wu, H., Tarr, P.T., Zhang, C.Y., Wu, Z., Boss, O., Michael, L.F., Puigserver, P., Isotani, E., Olson, E.N., et al. (2002). Transcriptional co-activator PGC-1 alpha drives the formation of slow-twitch muscle fibres. Nature 418, 797-801.
20. Matsakas, A., Macharia, R., Otto, A., Elashry, M.I., Mouisel, E., Romanello, V., Sartori, R., Amthor, H., Sandri, M., Narkar, V., and Patel, K. (2012a). Exercise training attenuates the hypermuscular phenotype and restores skeletal muscle function in the myostatin null mouse. Exp. Physiol. 97, 125-140.
21. Matsakas, A., Yadav, V., Lorca, S., Evans, R.M., and Narkar, V.A. (2012b). Revascularization of ischemic skeletal muscle by estrogen-related receptor-g. Circ. Res. 110, 1087-1096.
22. Milkiewicz, M., Pugh, C.W., and Egginton, S. (2004). Inhibition of endogenous HIF inactivation induces angiogenesis in ischaemic skeletal muscles of mice. J. Physiol. 560, 21-26.
23. Muscat, G.E., and Kedes, L. (1987). Multiple 5'-flanking regions of the human alpha-skeletal actin gene synergistically modulate muscle-specific expression. Mol. Cell. Biol. 7, 4089-4099.
24. Narkar, V.A., Fan, W., Downes, M., Yu, R.T., Jonker, J.W., Alaynick, W.A., Banayo, E., Karunasiri, M.S., Lorca, S., and Evans, R.M. (2011). Exercise and PGC-1α-independent synchronization of type I muscle metabolism and vasculature by ERRγ. Cell Metab. 13, 283-293.
25. O'Hagan, K.A., Cocchiglia, S., Zhdanov, A.V., Tambuwala, M.M., Cummins, E.P., Monfared, M., Agbor, T.A., Garvey, J.F., Papkovsky, D.B., Taylor, C.T., and Allan, B.B. (2009). PGC-1alpha is coupled to HIF-1alpha-dependent gene expression by increasing mitochondrial oxygen consumption in skeletal muscle cells. Proc. Natl. Acad. Sci. USA 106, 2188-2193.
26. Olfert, I.M., and Birot, O. (2011). Importance of anti-angiogenic factors in the regulation of skeletal muscle angiogenesis. Microcirculation 18, 316-330.
27. Pajusola, K., Künnapuu, J., Vuorikoski, S., Soronen, J., André, H., Pereira, T., Korpisalo, P., Ylä-Herttuala, S., Poellinger, L., and Alitalo, K. (2005). Stabilized HIF-1alpha is superior to VEGF for angiogenesis in skeletal muscle via adenoassociated virus gene transfer. FASEB J. 19, 1365-1367.
28. Pereira, F.A., Qiu, Y., Zhou, G., Tsai, M.J., and Tsai, S.Y. (1999). The orphan nuclear receptor COUP-TFII is required for angiogenesis and heart development. Genes Dev. 13, 1037-1049.
29. Qin, J., Chen, X., Xie, X., Tsai, M.J., and Tsai, S.Y. (2010). COUP-TFII regulates tumor growth and metastasis by modulating tumor angiogenesis. Proc. Natl. Acad. Sci. USA 107, 3687-3692.
30. Rowe, G.C., Jang, C., Patten, I.S., and Arany, Z. (2011). PGC-1β regulates angiogenesis in skeletal muscle. Am. J. Physiol. Endocrinol. Metab. 301, E155-E163.
31. Salehi, E., Khazaei, M., and Rashidi, B. (2012). Role of fenofibrate in restoring angiogenesis in diabetic and control hind limb ischemic rats. Gen. Physiol. Biophys. 31, 255-260.
32. Sarkar, K., Fox-Talbot, K., Steenbergen, C., Bosch-Marcé, M., and Semenza, G.L. (2009). Adenoviral transfer of HIF-1alpha enhances vascular responses to critical limb ischemia in diabetic mice. Proc. Natl. Acad. Sci. USA 106, 18769-18774.
33. Sawada, N., Jiang, A., Takizawa, F., Safdar, A., Manika, A., Tesmenitsky, Y., Kang, K.T., Bischoff, J., Kalwa, H., Sartoretto, J.L., et al. (2014). Endothelial PGC-1a mediates vascular dysfunction in diabetes. Cell Metab. 19, 246-258.
34. Semenza, G.L. (2009). Regulation of oxygen homeostasis by hypoxia-inducible factor 1. Physiology (Bethesda) 24, 97-106.
35. Semenza, G.L. (2012). Hypoxia-inducible factors in physiology and medicine. Cell 148, 399-408.
36. Simons, M., and Ware, J.A. (2003). Therapeutic angiogenesis in cardiovascular disease. Nat. Rev. Drug Discov. 2, 863-871.
37. Sonoda, J., Mehl, I.R., Chong, L.W., Nofsinger, R.R., and Evans, R.M. (2007). PGC-1beta controls mitochondrial metabolism to modulate circadian activity, adaptive thermogenesis, and hepatic steatosis. Proc. Natl. Acad. Sci. USA 104, 5223-5228.
38. van Weel, V., van Tongeren, R.B., van Hinsbergh, V.W., van Bockel, J.H., and Quax, P.H. (2008). Vascular growth in ischemic limbs: a review of mechanisms and possible therapeutic stimulation. Ann. Vasc. Surg. 22, 582-597.
39. Varu, V.N., Hogg, M.E., and Kibbe, M.R. (2010). Critical limb ischemia. J. Vasc. Surg. 51, 230-241.
40. Wood, S.M., Gleadle, J.M., Pugh, C.W., Hankinson, O., and Ratcliffe, P.J. (1996). The role of the aryl hydrocarbon receptor nuclear translocator (ARNT) in hypoxic induction of gene expression. Studies in ARNT-deficient cells. J. Biol. Chem. 271, 15117-15123.
41. Zhang, H., Gao, P., Fukuda, R., Kumar, G., Krishnamachary, B., Zeller, K.I., Dang, C.V., and Semenza, G.L. (2007). HIF-1 inhibits mitochondrial biogenesis and cellular respiration in VHL-deficient renal cell carcinoma by repression of C-MYC activity. Cancer Cell 11, 407-420.